← All companies

IBO

Impact BioMedical Inc.

IBO NYSE Pharmaceutical Preparations EDGAR ↗

$0.44

+0.00 +0.23%

Key statistics

from XBRL data in SEC filings

Market cap

$47.4M

Revenue (TTM)

$32.0K

Net income (TTM)

-$12.9M

EPS (TTM)

$-0.29

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$20.0K

Total assets

$17.1M

Gross margin

—

52-week range

$0.37 – $0.83

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Entered a material agreement Mar 4, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Shareholder vote results Nov 6, 2025 8-K Other events Oct 27, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement Jul 28, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Entered a material agreement Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Entered a material agreement Mar 28, 2025 8-K Director or officer change Mar 13, 2025 8-K Regulation FD disclosure Jan 29, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Regulation FD disclosure Nov 4, 2024 8-K Director or officer change Oct 8, 2024 8-K Entered a material agreement; Other events Sep 17, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 10-K Fiscal year ended 2023-12-31 Feb 20, 2024 8-K Entered a material agreement Jan 22, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Nov 6, 2023 10-Q Quarter ended 2023-06-30 Oct 5, 2023

Other filings

144 Apr 29, 2026 S-8 POS Apr 22, 2026 S-8 POS Apr 6, 2026 4 Mar 30, 2026 4 Mar 25, 2026 4 Jan 6, 2026 DEF 14C Dec 30, 2025 PRE 14C Dec 11, 2025 DEF 14A Sep 22, 2025 DEF 14C Sep 9, 2025 PRE 14C Aug 25, 2025 DEF 14C Aug 5, 2025 PRE 14C Jul 16, 2025